Form 4: Profound Medical Corp. CEO Increases Stake in Company

Sentiment:

SEC Form 4 Filing


CEO Arun Swarup Menawat reports purchasing additional Profound Medical Corp. shares in two transactions.

Better than expectedThe CEO increasing his stake in the company is a positive sign.

Summary

  • Arun Swarup Menawat, CEO of Profound Medical Corp., has reported purchasing additional common shares of the company.
  • On May 15, 2025, he acquired 10,003 shares at a weighted average price of $4.325, with individual prices ranging from $4.30 to $4.35.
  • Following this transaction, his direct ownership increased to 575,062 shares.
  • On May 16, 2025, Menawat purchased another 12,027 shares at a weighted average price of $4.73, with individual prices ranging from $4.70 to $4.78.
  • This further increased his direct ownership to 587,089 shares.
  • The report is voluntary and informational, as Profound Medical Corp. securities are currently exempt from Section 16 reporting requirements due to being a foreign private issuer.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the CEO's increased investment in the company, which suggests confidence in its future.

Positives

  • The CEO's increased investment in the company may signal confidence in Profound Medical Corp.'s future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued or that the company is poised for growth. However, it's important to consider the overall context and not rely solely on insider trading activity when making investment decisions.

Stakeholder Impact

  • Shareholders may view the CEO's increased stake as a positive signal, potentially leading to increased investor confidence.

Key Dates

DateDescription
05/15/2025CEO Arun Menawat purchased 10,003 common shares at a weighted average price of $4.325.
05/16/2025CEO Arun Menawat purchased 12,027 common shares at a weighted average price of $4.73.
05/20/2025Date of Form 4 signature.

Keywords

Profound Medical Corp, Insider Trading, Form 4, Beneficial Ownership, Arun Menawat, CEO, Share Purchase

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.